IMRX – immuneering corporation - class a (US:NASDAQ)
Stock Stats
News
Immuneering Leads The Pack Of 3 US Penny Stocks To Monitor [Yahoo! Finance]
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $13.00 price target on the stock.
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $15.00 price target on the stock.
Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates
Immuneering rises on orphan drug designation for treatment of pancreatic cancer [Seeking Alpha]
Form SC 13G/A Immuneering Corp Filed by: CITADEL ADVISORS LLC
Form SC 13G/A Immuneering Corp Filed by: Cormorant Asset Management, LP
Form 10-Q Immuneering Corp For: Sep 30
Form 8-K Immuneering Corp For: Nov 13
Form 8-K/A Immuneering Corp For: Mar 11
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.